Sign in

NCT03508934Active, not recruiting

Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes

Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans With DM2 at Higher Risk for Hypoglycemia

Source: ClinicalTrials.gov · Last updated 7 Jan 2026

Brief summary (registry, in English)

More than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans, the prevalence is disproportionally higher. It is estimated that 40-50% of hospitalized Veterans are diabetics. In this clinical trial the investigators describe the development of a novel system, the Glucose Telemetry System (GTS), with which glucose values can be wirelessly transmitted from the patient's bedside to a monitor device at the nursing station. The goal of this work is to develop a more effective glucose surveillance system at the general wards, which can decrease hypoglycemia in the hospital and improve clinical outcomes.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
218 (actual)
First submitted
10 Apr 2018
Start date
1 Jul 2018
Primary completion date
11 Jul 2025
Lead sponsor
VA Office of Research and Development
NCT number
NCT03508934

What you commit to

  • Study type: Interventional
  • Participants enrolled: 218
  • From 1 Jul 2018 to the primary completion date, 11 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Veterans receiving glucocorticosteroids in doses (equivalent) to 20 mg of hydrocortisone/day

Other illness

  • Veterans with history of type 1 DM.
  • Veterans with history of DM2 managed with diet or any combination of oral antidiabetic drugs only.

Other

  • Veterans hospitalized with significant hyperglycemia or diabetic ketoacidosis
  • Pregnant Veterans
  • Veterans that are expected to require a hospital stay \<3 days will also be excluded

Who the study is looking for

  • Veterans with history of DM2 managed with insulin (either basal bolus, basal only or basal with per os DM medications), admitted to the Baltimore VA Medical Center, who have at
    • least 1 risk factor of hypoglycemia

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.